Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06965023Recruiting

Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)

Role: collaborator

NCT05234164Not ApplicableTerminated

HORIZON Prospective Clinical Investigation

Role: collaborator

NCT05081115Recruiting

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

Role: collaborator

NCT03740425Completed

Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) Study

Role: collaborator

NCT02159430Unknown

Hereditary AngioEdema, Neurobiology and Psychopathology

Role: lead

NCT02147912Not ApplicableUnknown

Evaluation of Depression In Chronic Obstructive Pulmonary Disease

Role: lead

NCT01334684Not ApplicableUnknown

Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes

Role: collaborator

NCT01090284Unknown

The Immunologic Reaction to Polypropylene Mesh in Inguinal Hernioplasty

Role: lead

All 8 trials loaded